Skip to content
Search

Latest Stories

India's Covid-19 death toll reaches 335,102

India's Covid-19 death toll reaches 335,102

INDIA on Wednesday (2) reported a daily rise in new coronavirus infections of 132,788 cases over the past 24 hours, while deaths rose by 3,207.

The South Asian nation's tally of infections now stands at 28.3 million, while the death toll has reached 335,102, health ministry data showed. The daily positivity rate has further dropped to 6.57 per cent.


Recoveries continue to outnumber daily new cases for the 20th consecutive day.

The number of people who have recuperated from the disease surged to 26,179,085, while the case fatality rate stands at 1.18 per cent, the data stated.

The active cases were also recorded below two million for the second consecutive day, the ministry said.

As many as 2,019,773 tests were conducted on Tuesday (1) taking the total cumulative tests conducted so far in the country to 350,057,330.

The weekly positivity rate has declined to 8.21 per cent.The active cases have reduced to 1,793,645 comprising 6.34 per cent of the total infections, while the national Covid-19 recovery rate has improved to 92.48 per cent.

A net decline of 101,875 cases has been recorded in the Covid-19 caseload in a span of 24 hours.

The most number of fatalities are from Maharashtra (854), Tamil Nadu (490), Karnataka (464), Kerala (194), Uttar Pradesh (175), West Bengal (137) and Andhra Pradesh (104).

The health ministry stressed that more than 70 per cent of the deaths occurred due to comorbidities.

More For You

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Sinha’s message was one of resilience and realism

Getty

The Chase’s Paul Sinha shares Parkinson’s update after major health scare

Paul Sinha, known to viewers of ITV’s The Chase as “The Sinnerman,” has spoken candidly about his experience living with Parkinson’s disease. During an appearance on Loose Women on Thursday, 17 April, the comedian and quizzer reflected on his journey from diagnosis to managing the condition day to day.

Sinha, who was diagnosed with the progressive neurological disorder in 2019, revealed that his earliest symptoms were not what many would typically associate with Parkinson’s.

Keep ReadingShow less
Toblerone dark chocolate discontinued in the UK, confirms Mondelez

This reflects both the popularity of the product and the frustration of fans

iStock

Toblerone dark chocolate discontinued in the UK, confirms Mondelez

Toblerone fans in the UK will no longer be able to purchase the dark chocolate version of the iconic Swiss chocolate bar, as manufacturer Mondelez has confirmed it has discontinued the product.

The company stated that it has made the “difficult decision” to stop production of the 360g Toblerone Dark bar. While no specific reason was given, Mondelez acknowledged the disappointment it may cause among consumers. A spokesperson said: “While we understand that this may be disappointing for some consumers, we continue to invest in Toblerone.”

Keep ReadingShow less
Crispello Comeback: Cadbury’s Light Treat Hits B&M Shelves

The return to UK shelves has brought a wave of nostalgia for many

Getty

Cadbury Crispello chocolate bars return to UK shelves at B&M for 49p

Cadbury's Crispello chocolate bars have made a surprise return to UK stores, now available at B&M for just 49p. The product, a mix of light wafer and smooth chocolate, had previously been discontinued in the UK and was only available overseas in recent years.

Each individual pack of Crispello contains four chocolate-covered wafer fingers, filled with a creamy chocolate centre. The sweet treat has gained attention on social media, with shoppers expressing their excitement about its reappearance in British stores.

Keep ReadingShow less
 Sharon Osbourne

Celebrities including Sharon Osbourne and Oprah Winfrey might be exhibiting signs of this side effect

Instagram/ Sharonosbourne

‘Ozempic feet’ joins growing list of unusual side effects linked to popular weight-loss drug

Ozempic, the blockbuster weight-loss medication that has surged in popularity across the United States and among celebrities, is now being linked to a new and unexpected side effect like sagging skin on the feet, informally dubbed “Ozempic feet”.

Medical experts say the condition is caused by rapid fat loss, which not only alters the appearance of the face and buttocks, but can also lead to aesthetic changes in the feet. As the drug continues to make headlines for its weight-loss benefits, concerns about such side effects are also gaining attention.

Keep ReadingShow less